• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

启动子CpG岛高甲基化与II期结直肠癌患者的不良预后相关。

promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer.

作者信息

Wang Chuntao, Liu Yanliang, Guo Wenyi, Zhu Xu, Ahuja Nita, Fu Tao

机构信息

Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, People's Republic of China.

Department of Surgery, Yale School of Medicine, New Haven, CT, USA.

出版信息

Cancer Manag Res. 2019 Aug 5;11:7337-7343. doi: 10.2147/CMAR.S206731. eCollection 2019.

DOI:10.2147/CMAR.S206731
PMID:31496795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6689138/
Abstract

BACKGROUND

The methylation of microtubule-associated protein tau () was first described in patients with Alzheimer's disease. In this study, we aim to determine if promoter CpG island is hypermethylated and whether this signature could work as a prognostic marker for patients with stage II colorectal cancer (CRC).

METHODS

methylation level and CpG island methylator phenotype (CIMP) status were examined. The prognostic value of methylation was analyzed using Cox regression analysis.

RESULTS

Amongst stage II CRC patients (n=107), hypermethylation of promoter CpG island was seen in 23.4% of them. methylation was much more frequent in patients with age ≥60 compared to age <60 (0.001). were preferentially methylated among proximal colon tumors or CIMP high tumors (both 0.001). Five-year overall survival (OS) rates were 57.1% and 79.4% for patients with and without hypermethylation, respectively, HR=2.33 (95% CI, 1.19-4.57; 0.014). hypermethylation remained an important prognostic variable for OS in multivariate analysis with a HR of 2.29 (95% CI, 1.01-5.18; 0.047).

CONCLUSION

Our findings suggest that is frequently methylated and hypermethylation is associated with worse prognosis in patients with stage II CRC.

摘要

背景

微管相关蛋白tau()的甲基化最早在阿尔茨海默病患者中被描述。在本研究中,我们旨在确定tau启动子CpG岛是否发生高甲基化,以及这种特征是否可作为II期结直肠癌(CRC)患者的预后标志物。

方法

检测tau甲基化水平和CpG岛甲基化表型(CIMP)状态。使用Cox回归分析评估tau甲基化的预后价值。

结果

在II期CRC患者(n = 107)中,23.4%的患者存在tau启动子CpG岛的高甲基化。与年龄<60岁的患者相比,年龄≥60岁的患者中tau甲基化更为常见(P = 0.001)。在近端结肠肿瘤或CIMP高的肿瘤中,tau优先发生甲基化(均为P = 0.001)。tau高甲基化和未发生高甲基化的患者5年总生存率(OS)分别为57.1%和79.4%,HR = 2.33(95%CI,1.19 - 4.57;P = 0.014)。在多变量分析中,tau高甲基化仍然是OS的重要预后变量,HR为2.29(95%CI,1.01 - 5.18;P = 0.047)。

结论

我们的研究结果表明,tau在II期CRC患者中经常发生甲基化,且高甲基化与预后较差相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc4/6689138/de5ceea6c1f1/CMAR-11-7337-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc4/6689138/de5ceea6c1f1/CMAR-11-7337-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc4/6689138/de5ceea6c1f1/CMAR-11-7337-g0001.jpg

相似文献

1
promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer.启动子CpG岛高甲基化与II期结直肠癌患者的不良预后相关。
Cancer Manag Res. 2019 Aug 5;11:7337-7343. doi: 10.2147/CMAR.S206731. eCollection 2019.
2
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.RET基因启动子CpG岛甲基化预示II期结直肠癌患者预后不良。
Mol Oncol. 2014 May;8(3):679-88. doi: 10.1016/j.molonc.2014.01.011. Epub 2014 Feb 2.
3
Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients.错配修复蛋白1(MLH1)未甲基化且具有CpG岛甲基化表型的肿瘤与II期结直肠癌患者的预后不良相关。
Oncotarget. 2016 Dec 27;7(52):86480-86489. doi: 10.18632/oncotarget.13441.
4
Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?在CpG岛甲基化表型面板标记中甲基化程度达一半的结直肠癌的临床病理特征与CpG岛甲基化表型高的结直肠癌的临床病理特征是否不同?
Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.
5
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer.CpG 岛甲基化表型可能预测 IV 期结直肠癌患者的总体生存不良。
Oncology. 2019;96(3):156-163. doi: 10.1159/000493387. Epub 2018 Dec 12.
6
Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.全基因组甲基化分析确定了CIMP-H型结直肠癌中一组核心的高甲基化基因。
BMC Cancer. 2017 Mar 28;17(1):228. doi: 10.1186/s12885-017-3226-4.
7
Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.结直肠癌患者中CpG岛甲基化表型的预后价值:一项系统评价和荟萃分析。
Ann Oncol. 2014 Dec;25(12):2314-2327. doi: 10.1093/annonc/mdu149. Epub 2014 Apr 8.
8
Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.CpG 岛甲基化表型阴性远端结直肠癌的特征性甲基化谱。
Int J Cancer. 2010 Nov 1;127(9):2095-105. doi: 10.1002/ijc.25225.
9
CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.结直肠癌中的CpG岛甲基化表型:新型与经典CpG岛甲基化表型标志物组合的比较
Arch Pathol Lab Med. 2008 Oct;132(10):1657-65. doi: 10.5858/2008-132-1657-CIMPIC.
10
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.CHFR 启动子甲基化预示着 II 期微卫星稳定结直肠癌患者预后不良。
Clin Cancer Res. 2014 Jun 15;20(12):3261-71. doi: 10.1158/1078-0432.CCR-12-3734.

引用本文的文献

1
Accumulation of microtubule-associated protein tau promotes hepatocellular carcinogenesis through inhibiting autophagosome-lysosome fusion.微管相关蛋白tau的积累通过抑制自噬体-溶酶体融合促进肝细胞癌的发生。
Mol Cell Biochem. 2024 Dec 24. doi: 10.1007/s11010-024-05193-9.
2
Deciphering a hydrogen sulfide-related signature to supervise prognosis and therapeutic response in colon adenocarcinoma.解析与硫化氢相关的特征,以监测结肠腺癌的预后和治疗反应。
Medicine (Baltimore). 2024 Oct 11;103(41):e40031. doi: 10.1097/MD.0000000000040031.
3
Metabolic Rate and Oxidative Stress as a Risk Factors in the Development of Colorectal Cancer.

本文引用的文献

1
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
2
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.人类外周组织中特定tau蛋白种类的存在及其与阿尔茨海默病的关系。
J Alzheimers Dis. 2016 Oct 4;54(3):1249. doi: 10.3233/JAD-169007.
3
代谢率和氧化应激作为结直肠癌发展的危险因素。
Int J Mol Sci. 2024 Oct 5;25(19):10713. doi: 10.3390/ijms251910713.
4
Insights into Dysregulated Neurological Biomarkers in Cancer.癌症中神经生物标志物失调的见解
Cancers (Basel). 2024 Jul 27;16(15):2680. doi: 10.3390/cancers16152680.
5
Analyzing aberrant DNA methylation in colorectal cancer uncovered intangible heterogeneity of gene effects in the survival time of patients.分析结直肠癌中异常的 DNA 甲基化,揭示了患者生存时间中基因效应的无形异质性。
Sci Rep. 2023 Dec 13;13(1):22104. doi: 10.1038/s41598-023-47377-1.
6
Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma.基于免疫相关基因的signature 构建和分子亚型鉴定,以更好地预测肝细胞癌的预后。
BMC Med Genomics. 2023 Jun 14;16(1):130. doi: 10.1186/s12920-023-01558-z.
7
Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts.利用癌症基因组图谱(TCGA)队列对肥胖悖论及结直肠癌可能的相关因素进行生物信息学分析。
J Cancer. 2023 Jan 22;14(3):322-335. doi: 10.7150/jca.80977. eCollection 2023.
8
Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma.结肠腺癌中的铜代谢模式与肿瘤微环境特征
Front Oncol. 2022 Sep 20;12:959273. doi: 10.3389/fonc.2022.959273. eCollection 2022.
9
Systematic Analysis of Molecular Characterization and Clinical Relevance of Liquid-Liquid Phase Separation Regulators in Digestive System Neoplasms.消化系统肿瘤中液-液相分离调节因子的分子特征及临床相关性的系统分析
Front Cell Dev Biol. 2022 Feb 17;9:820174. doi: 10.3389/fcell.2021.820174. eCollection 2021.
10
The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol.酮体在结肠上皮细胞中的变构作用是由微管过度乙酰化介导的,并且可以被白藜芦醇所阻断。
Int J Mol Sci. 2021 Aug 30;22(17):9397. doi: 10.3390/ijms22179397.
Tau and tauopathies.
tau蛋白与tau蛋白病
Brain Res Bull. 2016 Sep;126(Pt 3):238-292. doi: 10.1016/j.brainresbull.2016.08.018. Epub 2016 Sep 9.
4
Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.前列腺肿瘤DNA甲基化与吸烟及不良前列腺癌预后相关。
Cancer. 2016 Jul 15;122(14):2168-77. doi: 10.1002/cncr.30045. Epub 2016 May 3.
5
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions.Tau 在生理和高热条件下对神经元 DNA 和 RNA 保护的主要作用。
Front Cell Neurosci. 2014 Mar 18;8:84. doi: 10.3389/fncel.2014.00084. eCollection 2014.
6
DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.帕金森病队列中MAPT基因的DNA甲基化及维生素E在体外的调节作用
Mov Disord. 2014 Nov;29(13):1606-14. doi: 10.1002/mds.25784. Epub 2013 Dec 27.
7
Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.人微管相关蛋白 tau 在体外介导靶向杀伤 CD30(+)淋巴瘤细胞,并在体内抑制肿瘤生长。
Br J Haematol. 2014 Jan;164(2):251-7. doi: 10.1111/bjh.12626. Epub 2013 Oct 25.
8
Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.散发性阿尔茨海默病中 CpG 甲基化的改变与 APP 和 MAPT 的失调有关。
Hum Mol Genet. 2014 Feb 1;23(3):648-56. doi: 10.1093/hmg/ddt451. Epub 2013 Sep 18.
9
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.微管相关蛋白 tau 有助于在体外和异种移植小鼠肿瘤模型体内靶向杀死增殖的癌细胞。
Br J Cancer. 2013 Sep 17;109(6):1570-8. doi: 10.1038/bjc.2013.457. Epub 2013 Aug 13.
10
CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis.CpG 岛甲基化表型阳性且 MLH1 未甲基化的肿瘤构成十二指肠腺癌的一个独特亚型,与预后不良相关。
Clin Cancer Res. 2012 Sep 1;18(17):4743-52. doi: 10.1158/1078-0432.CCR-12-0707. Epub 2012 Jul 23.